Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sodium lauryl sulfate safety trials should avoid "artificial" effects induction -- subcmte..

This article was originally published in The Tan Sheet

Executive Summary

SODIUM LAURYL SULFATE SAFETY STUDY METHODS IRRELEVANT TO CONSUMER PRACTICE as it relates to safety, according to Lewis Cancro, Cancro, Inc., Trumbull, Conn. Cancro, a nonvoting industry rep, said at FDA's Dental Product Panel Plaque Subcommittee meeting Dec. 16-17 in Bethesda, Md. that "the wearing of occlusive patches" of SLS to test for safety "really doesn't have relevance to the ways these products are used. Certainly the vast experience with [SLS] in this country and around the world doesn't suggest that it is problematic" with regard to safety concerns.
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086496

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel